Board of Directors 2022-2023
President (2022-2023)
Jan Elias Hansen, PhD
Vice President, Evidence for Access Unit - Genentech’s US Medical Affairs
Past President (2022-2023)
Isao Kamae, DrPH, MD,
Project Professor, Health Policy and Technology Assessment, University of Tokyo, Graduate School of Public Policy
Tokyo, Japan
President-Elect (2022-2023)
Brian O’Rourke, PharmD
President, Brian O'Rourke Health Care Consulting, Inc.
Ottawa, Canada
Director (2021-2024)
Beth Devine, PhD
Professor, Graduate program director, The Comparative Heath Outcomes, Policy and Economics (CHOICE) Institute, School of Pharmacy, University of Washington (UW)
Director (2021-2024)
Marlene Gyldmark, MPhil
Global Head HEOR and Epidemiology, Idorsia Pharmaceuticals Ltd
Director (2021-2024)
Andrea Manca, MSc PhD
Professor, Centre for Health Economics at the University of York
Biography and Vision Statement
Director (2020-2023)
Eberechukwu Onukwugha, PhD
Professor, University of Maryland
Baltimore, MD, USA
Director (2021-2023)
Lotte Steuten, MPhil
Vice-President and Head of Consulting at the Office of Health Economics and Honorary Visiting Professor at City, University of London, UK
Director (2021-2024)
Dong-Churl Suh, PhD
Professor and Director of the Graduate Program at the Chung-Ang University College of Pharmacy in Seoul, Korea
Director (2020-2023)
David Thompson, PhD
Chief Executive Officer, Open Health Evidence & Access
Boston, MA, USA
Treasurer (2020-2023)
Sean D. Sullivan, BScPharm, MSc, PhD,
Professor and Dean, University of Washington, School of Pharmacy
CEO & Executive Director
Rob Abbott
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, NJ, USA